Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Indivior Inc.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females between the ages of 18 to 55 years, inclusive
Diagnosis of schizophrenia as defined by Diagnostic and Statistical Manual, Edition 4, text revision (DSM-IV-TR) criteria
Subjects who are deemed "valid" by the State, Assessability, Face, Ecological, and Rule (SAFER) interview
Subjects who are otherwise healthy on the basis of their physical examination
You may not be if
Subjects who have an improvement in their total Positive and Negative Syndrome Scale (PANSS) score of 20% or greater between the initial screening visit and the first day of treatment.
Subjects taking daily oral risperidone at a dose ≥ 6 mg/day
Subjects who have received a depot antipsychotic within 120 days of screen
Subjects with treatment resistant schizophrenia, as judged by the investigator, who have been treated with antipsychotics for adequate durations and with adequate dosages.
Clareo Health | Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
